LENSAR, Inc.
LENSAR, Inc. (LNSR) Financial Performance & Income Statement Overview
Analyze LENSAR, Inc. (LNSR) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
LENSAR, Inc. (LNSR) Income Statement & Financial Overview
Review LENSAR, Inc. LNSR income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $14.16M | $16.73M | $13.54M | $12.64M |
| Cost of Revenue | $7.03M | $9.62M | $7.27M | $6.05M |
| Gross Profit | $7.13M | $7.11M | $6.27M | $6.58M |
| Gross Profit Ratio | $0.50 | $0.42 | $0.46 | $0.52 |
| R&D Expenses | $1.53M | $1.33M | $1.20M | $1.35M |
| SG&A Expenses | $11.15M | $6.83M | $6.08M | $6.78M |
| Operating Expenses | $12.68M | $8.40M | $7.28M | $8.13M |
| Total Costs & Expenses | $19.72M | $17.28M | $14.55M | $14.19M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $1.11M | $1.006M | $898000.00 |
| EBITDA | -$5.56M | -$184000.00 | -$239000.00 | -$653000.00 |
| EBITDA Ratio | -$0.39 | -$0.01 | -$0.02 | -$0.05 |
| Operating Income | -$5.56M | -$1.29M | -$1.01M | -$1.55M |
| Operating Income Ratio | -$0.39 | -$0.08 | -$0.07 | -$0.12 |
| Other Income/Expenses (Net) | -$21.79M | -$17.41M | -$489000.00 | -$7.49M |
| Income Before Tax | -$27.34M | -$18.70M | -$1.50M | -$9.04M |
| Income Before Tax Ratio | -$1.93 | -$1.12 | -$0.11 | -$0.72 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$27.34M | -$18.70M | -$1.50M | -$9.04M |
| Net Income Ratio | -$1.93 | -$1.12 | -$0.11 | -$0.72 |
| EPS | -$2.32 | -$1.61 | -$0.13 | -$0.79 |
| Diluted EPS | -$2.32 | -$1.61 | -$0.13 | -$0.79 |
| Weighted Avg Shares Outstanding | $11.77M | $11.63M | $11.60M | $11.45M |
| Weighted Avg Shares Outstanding (Diluted) | $11.77M | $11.63M | $11.60M | $11.45M |
The company's financials show resilient growth, with revenue advancing from $12.64M in Q2 2024 to $14.16M in Q1 2025. Gross profit remained healthy with margins at 50% in Q1 2025 compared to 52% in Q2 2024. Operating income hit -$5.56M last quarter, sustaining a consistent -39% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$5.56M. Net income dropped to -$27.34M, while earnings per share reached -$2.32. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan